BLGO · Biolargo, Inc.
$0.12
+0.01 (+9.09%)
At close · Jul 21
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The foregoing factors raise substantial doubt about our ability to continue as a going concern, unless we are able to increase revenues, generate cash from operations, and/or generate cash from financing activities.”View the 10-Q filed May 15, 2026
Market Cap
$38.51M
Shares
320.88M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.12
Open$0.11
Day$0.10–0.12
52W$0.10–0.23
Avg vol 30d340K
Short int6K · 0.0% float · 1.0d
Short vol36%
DataJan 2020–Jul 2026
Filing10-Q · May 15
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 15, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 18.7 · elevated
Equity put/call 0.66
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−24%
below
Price vs 50-day avg
−0%
below
RSI (14)
54
neutral
MACD trend
Positive
52-week position
15%
mid-range
Volume (OBV)
Bearish div.
distributing
Momentum
relative strength
1-month return
+13%
trailing
6-month return
−33%
trailing
YTD return
−33%
this year
Relative strength
−41%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
0% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.00% of float · ▲ +69.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
1 holders — near 3-yr low, contrarian setup
Squeeze score
26
low risk · 0–100
Fundamentals
Revenue growth
+4251%
Y/Y
Gross margin
28%
contracting
Free cash flow
$-8.3M
Balance sheet
$3.5M
net cash
Quant / Vol
risk profile
Volatility
87%
annualized · 1-yr
Max drawdown
−57%
past year
ATR
9.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−24%
Bearish
Price vs 50-day avg
−0%
Neutral
RSI (14)
54
Neutral
MACD trend
Positive
Bullish
52-week position
15%
Neutral
Volume (OBV)
Bearish div.
Bearish
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
0% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.00% of float · ▲ +69.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
1 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
52-wk low $0
Now $0 · 15%
52-wk high $0
vs 200-day avg -24%
vs 50-day avg 0%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BLGO
this stock
Biolargo, Inc.
|
$38.51M | -33.3% | +45.4% | — | 0.0% |
|
SHECF
Shin-Etsu Chemical Co., Ltd.
|
$81.08B | +44.5% | — | — | 0.3% |
|
DOW
Dow Inc.
|
$21.96B | +31.9% | -7.0% | — | 4.8% |
|
NPXYY
Nippon Sanso Holdings Corporation/ADR
|
$16.05B | +25.4% | — | — | 0.0% |
|
CE
Celanese Corp
|
$5.09B | +9.8% | -7.1% | — | 7.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Holders
1
- % held
- 0.0%
- Net QoQ
- 0 sh
- Top holder
- FIRST AMERICAN TRUST, FSB
Held
Float
Short & Settlement
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BLGO | +0.0% | +13.2% | -33.3% | +9.1% | -33.3% |
| SPY | -0.5% | +0.5% | +7.6% | +0.2% | +9.7% |
| vs SPY | +0.5% | +12.7% | -40.9% | +8.9% | -43.1% |